Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

496 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hepatocellular carcinoma: recent trends in the United States.
El-Serag HB. El-Serag HB. Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34. doi: 10.1053/j.gastro.2004.09.013. Gastroenterology. 2004. PMID: 15508094 Review.
Risk factors for the rising rates of primary liver cancer in the United States.
El-Serag HB, Mason AC. El-Serag HB, et al. Arch Intern Med. 2000 Nov 27;160(21):3227-30. doi: 10.1001/archinte.160.21.3227. Arch Intern Med. 2000. PMID: 11088082
Epidemiology of hepatocellular carcinoma.
el-Serag HB. el-Serag HB. Clin Liver Dis. 2001 Feb;5(1):87-107, vi. doi: 10.1016/s1089-3261(05)70155-0. Clin Liver Dis. 2001. PMID: 11218921 Review.
Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer.
El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. El-Serag HB, et al. Am J Gastroenterol. 2001 Jul;96(7):2013-8. doi: 10.1111/j.1572-0241.2001.03934.x. Am J Gastroenterol. 2001. PMID: 11467626
The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.
Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY. Hassan MM, et al. J Clin Gastroenterol. 2001 Aug;33(2):123-6. doi: 10.1097/00004836-200108000-00006. J Clin Gastroenterol. 2001. PMID: 11468438
Interferon: benefit beyond hepatitis therapy?
Mallat DB, El-Serag HB. Mallat DB, et al. Am J Gastroenterol. 2001 Dec;96(12):3435-6. doi: 10.1111/j.1572-0241.2001.05371.x. Am J Gastroenterol. 2001. PMID: 11774964 No abstract available.
496 results
Jump to page
Feedback